Insights
Trending Now
Emerging markets rebounded in 2025, outperforming U.S. and global equities as easing inflation, supportive policy and AI-led innovation drove a durable shift toward renewed leadership.
Pharmaceutical companies are navigating a changing landscape defined by GLP-1 innovation, AI-supported drug discovery, and evolving healthcare consumption patterns.
Trending Funds
_ of _